E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPACEI1861(ACE-inhibitory peptide)
DFBP ID DFBPACEI1861
Peptide sequence RNDDLNYIQ
Type Native peptide
Peptide/Function name ACE-inhibitory peptide
Function-activity relationship
Main bioactivity ACE-inhibitory activity
Otheir bioactivity Antioxidative activity [D1], DPP IV-inhibitory activity [D2], Multifunctional activity [D3]
Calculated physicochemical properties
Three-letter amino acid Arg-Asn-Asp-Asp-Leu-Asn-Tyr-Ile-Gln
Single-letter amino acid RNDDLNYIQ
Peptide length 9
Peptide mass
Experimental mass Theoretical mass
1150.542 Da 1150.20 Da c
Net charge 0.00 c
Isoelectric point (pI) 3.92 c
IC50 3.72 umol/L
pIC50 -0.571
GRAVY -1.6667 c
Hydrophilic residue ratio 22.22% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Egg
Precursor protein Egg-yolk protein by-product
Residue position N.D
Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
ACE-inhibitory activity

The peptide exhibited strong Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) inhibitory activity with an IC50 value of 3.72 umol/L.

Specific target protein(s) Specific Target Protein(s):
Angiotensin-converting enzyme
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Non-bitter taste prediction
SMILES N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)O
Preparation method
Mode of preparation

Enzymatic hydrolysis

Enzyme(s)/starter culture

Enzymatic hydrolysis conducted using unconventional enzyme from Cucurbita ficifolia (dose: 1000 U/mg of hydrolyzed egg-yolk protein (E/S (w/w) = 1:7.52)) was employed to obtain protein hydrolysates. The 4-h hydrolysate exhibited a significant (IC50 = 482.5 μg/mL) ACE inhibitory activity.

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report:

The MTT assay results indicated that Egg-yolk protein hydrolysate used in concentrations of 1% and 10% did not show toxicity to animal and human cell lines during 48 h of incubation. Moreover, it may slightly affect the growth of Balb 3T3 cell lines, as shown in Table 1.

Table 1. Cytotoxic/proliferation activity of egg yolk protein hydrolysate obtained with using a serine proteinase from C. ficifolia (1000 U/mg of hydrolyzed Egg-yolk protein (E:S (w/w) = 1:7.52). Tested cell lines: mouse fibroblasts (Balb3T3), human hepatocytes (HepG2) and human keratinocytes (HaCaT). All data were expressed as mean values (mean ± SD, n = 3).
Hydrolysate
MTT test A 560 nm
Balb 3T3
HepG2
HaCaT
0
0.07 ± 0.01
0.17 ± 0.04
0.05 ± 0.02
1
0.07 ± 0.02
0.17 ± 0.03
0.05 ± 0.01
10
0.13 ± 0.02
0.17 ± 0.02
0.05 ± 0.02
Prediction: ToxinPred
Additional information
Additional information

Egg-yolk protein hydrolysate showed no cytotoxic activity on human and animal cell lines which makes it a very useful multifunctional method for peptide preparation. The research indicates the possibility of using of Egg-yolk protein hydrolysate as additive in functional foods, pharmacological substances or cosmetics.

Database cross-references
DFBP
[D1] DFBPANOX0455
[D2] DFBPDPIV0032
[D3] DFBPMUFU0570
BIOPEP-UWM [D4] 8387, 8552, 8553
APD [D5] -
BioPepDB [D6] -
MBPDB [D7] -
Reference(s)
Primary literature Eckert E, Zambrowicz A, Pokora M, Setner B, Dąbrowska A, Szołtysik M, Szewczuk Z, Polanowski A, Trziszka T, Chrzanowska J. Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia). J Proteomics. 2014 Oct 14;110:107-16.
PMID: 25138009
Other literature(s) N.D
PubDate 2014
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214